Latest News

Wideblue customer CRiL start clinical trials at Addenbrookes hospital with new NTC1 product

Cambridge Respiratory Innovations Ltd have received approval to start clinical trials of the new NTC1 product designed and built by Wideblue. Approval was given for the trials by the Cambridge University Hospitals NHS Foundation Trust for “clinical evaluation of the CRIL N-Tidal C data-collector capnometer to collect breathing records in patients with COPD”. Patients with COPD will be recruited for the trial starting in February and given a N Tidal C device to record their capnometry / CO2 breathing records over a few weeks. The trials are due to be completed by the 18th April 2016.

Wideblue complete build of CRiL new NTC1 medical devices for clinical trials

Following the completion of the SOSRC project, Wideblue have commissioned new production quality injection moulding tooling, electronics boards and Infra Red optics to allow the assembly and testing of a new N Tidal C medical device (NTC1) for CRiL (Cambridge Respiratory Innovations Ltd).

This is the first device to be formally tested and is configured as a personal data capture device for the purposes of the COPD clinical trial. In addition to the manufacture and testing of over 30 new medical devices for the trial, Wideblue have also prepared spare units, disposable mouthpieces, diagrams for the various Instruction Manuals, software for the clinical trial users and suitable labelling and packaging.

The devices, which are CE marked by CRiL, have been manufactured under Wideblue’s ISO13485 quality systems.

Wideblue complete Solid State Optical Respiration Rate Capnometer (SOSORC) project on time and on budget

Wideblue and partners GSS and CRiL have successfully completed the Innovate UK SOSORC project. This Innovate UK supported project, which started in 2014, aimed to use GSS CO2 sensors in a range of medical devices and prove their effectiveness in a range of clinical applications.

Wideblue, who lead this project, have incorporated updated GSS sensors into standard oxygen masks for measurement of respiration rate and into a new range of small personal battery powered handheld capnometers for a wide variety of possible clinical applications.

The Innovate UK monitoring officer said in the final report: “The project is now complete within the given timeframe. All objectives detailed in the application have been achieved. Additional work has been carried out. The consortium are ready for the clinical trials to commence. They are in a very good position to take the project forward to the next stage. Excellent project, and very well managed technically and administratively”.

Wideblue Customer CRiL Achieve ISO 13485

Congratulations to Wideblue’s customer Cambridge Respiratory Innovations Limited (CRiL), who have recently gained accreditation to ISO9001 and ISO13485.

Wideblue have completed the design, tooling, and DFM of CRiL’s first product, the N Tidal C, in less than 10 months. This is a new, ultra-fast, ultra-sensitive, low cost personal medical device to accurately monitor CO2 in exhaled breath. The production quality devices are currently being built by Wideblue and are due to start clinical trials with patients’ suffering from COPD early next year.

By achieving accreditation to ISO13485, CRiL are one step closer to bringing this groundbreaking product to market.

Wideblue finalists at British Engineering Excellence Awards

Wideblue founders Grant King and Russell Overend attended the British engineering excellence awards (BEEAs) in London where Wideblue were finalists in the Best Small Company of the Year category.

Russell said “It was a great achievement and a huge honour to be nominated and reach the finals of such a prestigious award. The event was attended by the best in British engineering and showcased the strength, depth and breadth of UK engineering talent. Congratulations to all the finalists and winners”.